Related Experiment Videos
Thrombotic microangiopathy in advanced prostatic carcinoma
Suzanne M Biers1, Mark E Sullivan, Ian S D Roberts
1Department of Urology, Churchill Hospital, Oxford, United Kingdom.
Urology
|February 20, 2004
Summary
Acute renal failure in advanced prostate cancer can be caused by thrombotic microangiopathy, not just obstruction. This rare finding highlights the importance of considering unusual causes of kidney failure in cancer patients.
Area of Science:
- Nephrology
- Oncology
- Pathology
Background:
- Advanced prostate carcinoma presents unique challenges in patient management.
- Acute renal failure (ARF) is a serious complication in cancer patients.
Observation:
- A patient with advanced prostate carcinoma developed ARF.
- Initial assessment suggested renal tract obstruction, but treatment with dialysis and nephrostomy was ineffective.
Findings:
- Postmortem examination revealed severe thrombotic microangiopathy (TMA) as the cause of ARF.
- TMA is a condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
Implications:
- This case underscores the importance of considering TMA in cancer patients with unexplained ARF.
- Recognizing TMA can lead to timely diagnosis and potentially different therapeutic strategies.
- Further research into the mechanisms linking prostate cancer and TMA is warranted.